Abstract：【Objective】To investigate the therapeutic effect of tripterygium glycosides combined pancreatic kininogenase in the treatment of diabetic nephropathy. 【Methods】A total of 80 patients of diabetic nephropathy who received therapy from March 2016 to Nov 2017 in our hospital were selected as research subjects. According to the stochastic indicator method, patients were divided into the observation group and the control group. Patients in the control group received pancreatic kininogenase treatment, while patients in the observation group received tripterygium glycosides combined with pancreatic kininogenase treatment. Clinical efficacy, levels of homocysteine (Hcy),hypersensitive C-reactive protein (hs-CRP) before and after treatment, renal function indicators (blood urea nitrogen-BUN, urinary creatinine-UCr and 24h urine protein quantification-UP) and blood glucose index (fasting blood glucose-FPG, 2h post-prandial blood sugar-2hPG and glycosylated hemoglobin-HbAlc) were compared between the two groups. The adverse reactions were also observed during treatment.【Results】The total effective rate of the observation group was 87.50%, which was significantly higher than that of the control group (67.50%).The difference between the two groups was statistically significant (P<0.05). After treatment, the levels of Hcy, hs-CRP, BUN, UCr,UP,FPG,2hPG and HbAlc in the observation group were significantly lower than those of the control group (P<0.05). One patient in the observation group had a slight increase in alanine aminoase after 1 month of treatment, and returned to normal after symptomatic treatment. No adverse reactions occurred in the control group. There was no significant difference in the incidence of adverse reactions between the observed group and the control group (P>0.05). 【Conclusion】Tripterygium glycosides combined with pancreatic kininogenase in the treatment of DN can significantly reduce serum inflammatory factors and blood glucose levels, improve renal function. It is safe and worthy of clinical application.
王姝琴, 王德琴. 雷公藤多苷联合胰激肽原酶治疗糖尿病肾病的疗效观察[J]. 医学临床研究, 2018, 35(10): 1902-1904.
WANG Shu-qin, WANG De-qin. Therapeutic effect of Tripterygium Glycosides Combined with Pancreatic Kininogenase in Treatment of Diabetic Nephropathy. JOURNAL OF CLINICAL RESEARCH, 2018, 35(10): 1902-1904.
2018, Vol. 35 
